COVID–19 Emergency Medical Supplies Enhancement Act of 2021
- Last Action
- 5/19/2021
Actions
- 2021-05-19Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
- 2021-05-18Motion to reconsider laid on the table Agreed to without objection.
- 2021-05-18On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2456-2457)
- 2021-05-18Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H2456-2457)
- 2021-05-18DEBATE - The House proceeded with forty minutes of debate on H.R. 3125.
- 2021-05-18Considered under suspension of the rules. (consideration: CR H2456-2458)
- 2021-05-18Mr. Cleaver moved to suspend the rules and pass the bill.
- 2021-05-11Referred to the House Committee on Financial Services.
- 2021-05-11Introduced in House
- 2021-05-11Introduced in House
CRS Summary
As of 2021-05-18 (53)
COVID-19 Emergency Medical Supplies Enhancement Act of 2021
This bill expands certain authorities under the Defense Production Act of 1950 (DPA) and authorizes the President and federal agencies to take specific actions to support the production of critical medical supplies during the COVID-19 (i.e., coronavirus disease 2019) emergency, including with respect to private-sector coordination, needs assessments, and overall strategies.
The bill makes loans under the DPA subject to certain notification requirements.
A report required under the DPA for FY2022 and FY2023 shall include the percentage of contracts awarded to small businesses.
Cosponsors (4)
- J. Hill (R-AR)
- Van Taylor (R-TX)
- TIM RYAN (D-OH)
- Jenniffer Gonzalez-Colon (R-PR)
Subjects
- Administrative law and regulatory procedures
- Cardiovascular and respiratory health
- Congressional oversight
- Drug therapy
- Emergency medical services and trauma care
- Government lending and loan guarantees
- Health promotion and preventive care
- Health technology, devices, supplies
- Infectious and parasitic diseases
- Manufacturing
- Medical tests and diagnostic methods
- Military procurement, research, weapons development
- Public contracts and procurement
- Public-private cooperation
- Small business
- Strategic materials and reserves
- Worker safety and health
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.